BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 5, 2014
View Archived Issues
Genocea Biosciences joins collaboration to characterize T-cell responses to cancer antigens
Read More
Ohr Pharmaceutical and Cold Spring Harbor Laboratory to develop trodusquemine
Read More
S1 Biopharma to begin phase IIa trial of Orexa for low male sexual desire
Read More
Cardium collaborates with Taxus Pharmaceuticals for regenerative therapeutics
Read More
BAX as a novel susceptibility gene for Crohn's disease
Read More
Dynavax updates status of AstraZeneca collaboration
Read More
Northern Manhattan Study links markers of infection and neuroendocrine dysfunction with stroke risk
Read More
Tracon and Santen sign agreement for TRC-105 in ophthalmology
Read More
Insight Genetics enters triple-negative breast cancer marker collaboration
Read More
Biogen Idec disclose new ROR-gamma receptor modulators
Read More
Researchers at Roche present novel mGlu5 receptor modulators
Read More
Novel HIV integrase inhibitors disclosed by Bristol-Myers Squibb
Read More
Australian group divulges new VEGFR inhibitors for cancer
Read More
CCFA Microbiome and Genetics Initiatives seek personalized treatments for IBD
Read More
Adasuve now available in the U.S.
Read More
Forest Laboratories submits NDA for memantine and donepezil combination
Read More
Bioheart reports 6-month data from phase I ANGEL trial
Read More
Longer-acting clotting factor FVIIa-CTP shows promise, obtains FDA orphan drug designation
Read More
Theravance provides update on separation date for its businesses
Read More
FDA lifts clinical hold from Oxycyte development program
Read More
Cornerstone Pharmaceuticals presents preclinical data on CPI-613 for NSCLC
Read More
Enrollment completed in Celladon's CUPID 2 trial for advanced heart failure
Read More
Santhera to present data from expanded access program of Raxone for LHON
Read More
Xoma will not advance gevokizumab into pivotal program for erosive osteoarthritis of the hand
Read More